News - Tarceva, Markets & Marketing


Popular Filters

Turkey's NSCLC drug market forecast to expand at 7% a year through 2017


From 2012 to 2017, the non-small-cell lung cancer (NSCLC) market in Turkey will increase at an annual…

AlimtaBiotechnologyEli LillyEuropeMarkets & MarketingOncologyPharmaceuticalRocheTarceva

75% of US oncologists prescribe Pfizer's Xalkori just 10 months after the drug's launch


US oncologists surveyed by advisory firm Decision Resources say they prescribe drugs behemoth Pfizer's…

GlaxoSmithKlineHerceptinMarkets & MarketingNorth AmericaOncologyPfizerPharmaceuticalResearchRocheTarcevaTykerbXalkori

European oncologists indicate Tarceva will threaten market position of Iressa in mutated EGFR NSCLC


According to the majority of surveyed oncologists in the European Union 5 (France, Germany, Italy, Spain…

AstraZenecaEuropeIressaMarkets & MarketingOncologyPharmaceuticalRocheTarceva

Back to top